A few years ago, nobody had heard of Ozempic, Wegovy or Mounjaro. Now they are part of a growing number of people’s daily life. And a possible threat to wine.
Afternoon Brief, April 3
Afternoon Brief: Who’s Afraid of American Wine?: A simple standard is facing serious resistance. The real question is: who benefits from keeping it that way?



0 Comments